Establishment of linkage phase, using Oxford Nanopore Technologies, for preimplantation genetic testing of Coffin-Lowry syndrome with a de novo RPS6KA3 mutation

Background: This study aimed to perform preimplantation genetic testing (PGT) for a female Coffin-Lowry Syndrome (CLS) patient with a de novo mutation (DNM) in RPS6KA3. It was challenging to establish the haplotype in this family because of the lack of information from affected family members. Hence, we explored a new and reliable strategy for the detection of the DNM in PGT, using Oxford Nanopore Technologies (ONT) and the MARSALA platform.Methods: We performed whole-exome sequencing (WES) on the proband and confirmed the pathogenic mutation by Sanger sequencing. The proband then underwent PGT to prevent the transmission of the pathogenic mutation to her offspring. We diverged from the conventional methods and used long-read sequencing (LRS) on the ONT platform to directly detect the mutation and nearby SNPs, for construction of the haplotype in the preclinical phase of PGT. In the clinical phase of embryo diagnosis, the MARSALA method was used to detect both the SNP-based haplotype and chromosome copy number variations (CNVs), in each blastocyst. Finally, a normal embryo was selected by comparison to the haplotype of the proband and transferred into the uterus. Sanger sequencing and karyotyping were performed by amniocentesis, at 17 weeks of gestation, to confirm the accuracy of PGT.Results: Using WES, we found the novel, heterozygous, pathogenic c.1496delG (p.Gly499Valfs*25) mutation of RPS6KA3 in the proband. The SNP-based haplotype that was linked to the pathogenic mutation site was successfully established in the proband, without the need for other family members to be tested with ONT. Eight blastocysts were biopsied to perform PGT and were assessed with a haplotype linkage analysis (30 SNP sites selected), to give results that were consistent with direct mutation detection using Sanger sequencing. The results of PGT showed that three of the eight blastocysts were normal, without the DNM. Moreover, the patient had a successful pregnancy, after transfer of a normal blastocyst into the uterus, and delivered a healthy baby.Conclusion: The ONT platform, combined with the MARSALA method, can be used to perform PGT for DNM patients without the need for other samples as a reference

Effect of Larvae Treated with Mixed Biopesticide Bacillus thuringiensis - Abamectin on Sex Pheromone Communication System in Cotton Bollworm, Helicoverpa armigera

Third instar larvae of the cotton bollworm (Helicoverpa armigera) were reared with artificial diet containing a Bacillus thuringiensis - abamectin (BtA) biopesticide mixture that resulted in 20% mortality (LD(20)). The adult male survivors from larvae treated with BtA exhibited a higher percentage of “orientation” than control males but lower percentages of “approaching” and “landing” in wind tunnel bioassays. Adult female survivors from larvae treated with BtA produced higher sex pheromone titers and displayed a lower calling percentage than control females. The ratio of Z-11-hexadecenal (Z11–16:Ald) and Z-9-hexadecenal (Z9–16:Ald) in BtA-treated females changed and coefficients of variation (CV) of Z11–16:Ald and Z9–16:Ald were expanded compared to control females. The peak circadian calling time of BtA-treated females occurred later than that of control females. In mating choice experiment, both control males and BtA-treated males preferred to mate with control females and a portion of the Bt-A treated males did not mate whereas all control males did. Our Data support that treatment of larvae with BtA had an effect on the sex pheromone communication system in surviving H.armigera moths that may contribute to assortative mating

Cochlear Implant Electrode Choice in Challenging Surgical Cases: Malformation, Residual Hearing, Ossification, or Reimplantation

The limits of cochlear implantation candidacy have been expanding over the last decade and recent studies show that patients with inner ear anomalies, significant residual hearing, ossified cochlea, or far advanced otosclerosis can benefit from implant. The cochlear implant companies are coming up with various electrode designs. The purpose of this study is to review the factors that can affect the choice of electrode array in the expanding indications of cochlear implantation and suggest some surgical tips.A comprehensive preoperative evaluation is crucial. Detailed audiologic examination and radiologic assessment of inner ear structures with high-resolution computed tomography and/or magnetic resonance imaging is necessary. The choice of electrode array should be made regarding the type of cochlea in the presence of inner ear anomalies. If the patient has residual hearing in low-frequencies, electrode array and surgical insertion technique should be as atraumatic as possible to protect apical part of the cochlea. Appropriate selection of electrodes and surgical techniques are necessary if the cochlea is obstructed by fibrosis or ossified. The surgeon also should consider the possibility of reimplantation in the future and select the initial electrode after comprehensive evaluation.There is a diversity of electrode arrays for different indications. The selection of the most accurate electrode depends on the audiological tests, etiology of hearing loss, and cochlear anatomy. Surgeon must be prepared preoperatively for various clinical situations and unexpected surgical circumstances. One should keep in mind that making the right electrode choice will impact the outcomes of unusual or challenging cases